Sultiam, also known as Sulthiame and marketed under the brand name Ospolot, is a sulfonamide derivative primarily used as an anticonvulsant medication for treating epilepsy in certain countries. It has also shown potential in recent studies for the treatment of obstructive sleep apnea (OSA).